Healthy adults with or without a tendency for constipation
Conditions
Interventions
Intervention Test tablets (containing lactic acid bacteria powder) Duration: 4 weeks Amount: 4.4 g daily
Control Placebo tablets Duration: 4 weeks Amount: 4.4 g daily
Sponsors
Clinical Support Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Japanese untreated males and females from 20 to 69 years of age. (2) Those judged as suitable for the study by the principal investigator. (3) Those who gave the written informed consent before the study.
Exclusion criteria
Exclusion criteria: (1) A medical history of severe disorders, or continuous medical treatment. (2) A surgical history of digestive system (except appendicectomy) (3) Constantly usage of medical agents for constipation, supplements and/or functional foods (including Food for Specified Health Uses [FOSHU]) for intestinal regulation. (4) With allergy to lactic acid bacteria, milk, soybean, or citrus/ (5) Those who are pregnant or have possibility to become pregnant during the study or breast-feeding. (6) Those who drink alcohol a lot or heavy smoker. (7) Those having an extremely irregular diet habit (unexpectedly skipping three or more meals a week) (8) Alternative work schedule, or work on midnight shift. (9) Those who are participating or plan to participate the other clinical tests (foods, medicines, cosmetics or liniments) during the study. (10) Those judged as unsuitable for the study by the principal investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of side effects during intervention | — |
Countries
Japan
Contacts
Public ContactIsao Takehara
Clinical Support Corporation PI-Food Service Division
Outcome results
None listed